DK0697885T3 - Insulinlignende vækstfaktor II som antitumormiddel - Google Patents
Insulinlignende vækstfaktor II som antitumormiddelInfo
- Publication number
- DK0697885T3 DK0697885T3 DK94915218T DK94915218T DK0697885T3 DK 0697885 T3 DK0697885 T3 DK 0697885T3 DK 94915218 T DK94915218 T DK 94915218T DK 94915218 T DK94915218 T DK 94915218T DK 0697885 T3 DK0697885 T3 DK 0697885T3
- Authority
- DK
- Denmark
- Prior art keywords
- pct
- insulin
- growth factor
- antitumor agent
- medicament
- Prior art date
Links
- 102000048143 Insulin-Like Growth Factor II Human genes 0.000 title abstract 2
- 108090001117 Insulin-Like Growth Factor II Proteins 0.000 title abstract 2
- 239000002246 antineoplastic agent Substances 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 3
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000030381 cutaneous melanoma Diseases 0.000 abstract 1
- 230000009036 growth inhibition Effects 0.000 abstract 1
- 201000001441 melanoma Diseases 0.000 abstract 1
- 201000003708 skin melanoma Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939310049A GB9310049D0 (en) | 1993-05-12 | 1993-05-12 | Growth factor effects |
| PCT/GB1994/001030 WO1994026300A1 (en) | 1993-05-12 | 1994-05-12 | Insulin-like growth factor ii as antitumour agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0697885T3 true DK0697885T3 (da) | 2001-12-31 |
Family
ID=10735556
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK94915218T DK0697885T3 (da) | 1993-05-12 | 1994-05-12 | Insulinlignende vækstfaktor II som antitumormiddel |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5902788A (da) |
| EP (1) | EP0697885B1 (da) |
| JP (1) | JPH08510230A (da) |
| AT (1) | ATE205398T1 (da) |
| AU (1) | AU682862B2 (da) |
| CA (1) | CA2162594A1 (da) |
| DE (1) | DE69428276T2 (da) |
| DK (1) | DK0697885T3 (da) |
| ES (1) | ES2166778T3 (da) |
| GB (1) | GB9310049D0 (da) |
| NZ (1) | NZ265994A (da) |
| PT (1) | PT697885E (da) |
| WO (1) | WO1994026300A1 (da) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6630168B1 (en) * | 1997-02-20 | 2003-10-07 | Biomedicines, Inc. | Gel delivery vehicles for anticellular proliferative agents |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0346429B1 (en) * | 1987-12-24 | 1994-12-28 | Gropep Pty. Ltd. | Peptide analogues of insulin-like growth factor 1 (igf-1) or factor 2 (igf-2) |
| SE9101341D0 (sv) * | 1991-05-03 | 1991-05-03 | Kabi Pharmacia Ab | New medicinal use |
| US5202119A (en) * | 1991-06-28 | 1993-04-13 | Genentech, Inc. | Method of stimulating immune response |
-
1993
- 1993-05-12 GB GB939310049A patent/GB9310049D0/en active Pending
-
1994
- 1994-05-12 AT AT94915218T patent/ATE205398T1/de not_active IP Right Cessation
- 1994-05-12 NZ NZ265994A patent/NZ265994A/en unknown
- 1994-05-12 EP EP94915218A patent/EP0697885B1/en not_active Expired - Lifetime
- 1994-05-12 PT PT94915218T patent/PT697885E/pt unknown
- 1994-05-12 CA CA002162594A patent/CA2162594A1/en not_active Abandoned
- 1994-05-12 AU AU66547/94A patent/AU682862B2/en not_active Ceased
- 1994-05-12 DK DK94915218T patent/DK0697885T3/da active
- 1994-05-12 JP JP6525163A patent/JPH08510230A/ja active Pending
- 1994-05-12 ES ES94915218T patent/ES2166778T3/es not_active Expired - Lifetime
- 1994-05-12 US US08/549,676 patent/US5902788A/en not_active Expired - Fee Related
- 1994-05-12 DE DE69428276T patent/DE69428276T2/de not_active Expired - Fee Related
- 1994-05-12 WO PCT/GB1994/001030 patent/WO1994026300A1/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| EP0697885B1 (en) | 2001-09-12 |
| ES2166778T3 (es) | 2002-05-01 |
| ATE205398T1 (de) | 2001-09-15 |
| DE69428276D1 (de) | 2001-10-18 |
| WO1994026300A1 (en) | 1994-11-24 |
| US5902788A (en) | 1999-05-11 |
| EP0697885A1 (en) | 1996-02-28 |
| AU6654794A (en) | 1994-12-12 |
| CA2162594A1 (en) | 1994-11-24 |
| DE69428276T2 (de) | 2002-05-16 |
| AU682862B2 (en) | 1997-10-23 |
| JPH08510230A (ja) | 1996-10-29 |
| NZ265994A (en) | 2001-02-23 |
| GB9310049D0 (en) | 1993-06-30 |
| PT697885E (pt) | 2002-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2136723T3 (es) | Utilizacion de n-aril-metilen-etilen-diamino-triacetatos, n-aril-metilen-imino-diacetatos o n,n'-diaril-metilen-etilen-diamino-acetatos contra el estres oxidante. | |
| AU678795B2 (en) | Application of riluzole in the treatment of neurological lesions related to traumatic injuries | |
| NO954996D0 (no) | Anvendelse av nona- og dekapeptider for fremstilling av et legemiddel for behandling av AIDS | |
| AU685075B2 (en) | Pharmaceutical composition for treating nicotine dependence | |
| FI964332A0 (fi) | Eräiden metaanibisfosfonihappojohdannaisten käyttö proteesin löystymisen ja proteesin vaelluksen estämiseen | |
| DK0697885T3 (da) | Insulinlignende vækstfaktor II som antitumormiddel | |
| ES2175153T3 (es) | Uso de inhibidores de colinesterasa para la fabricacion de un medicamento para el tratamiento de la xerostomia. | |
| NO981320L (no) | Oral anvendelse av (+)-O-demetyltramadol som smertemiddel | |
| AU5625194A (en) | Rectal flunisolide compositions for treating inflammatory intestinal disorders | |
| NO307204B1 (no) | Anvendelse av riluzol ved fremstilling av medikamenter ved behandling av stråleskader | |
| IL107917A0 (en) | Triazoloquinazolines, their preparation and their use as medicaments | |
| NO984965L (no) | Komponent B som cicatrisant | |
| UA30359A (uk) | Спосіб лікування гнійних ран |